Materials and Methods
Culture maintenance. Stocks of Mycoplasma sp. RP III were grown in a medium based on Difco PPLO broth (without crystal violet) to which was added 0.5 % yeast extract and 1 % sterile calf serum. Aliquots were frozen at -20°C and stored until needed. Fermentations were started using inoculum grown on PPLO broth medium for 24 hours at 35°C in shaken flasks. Although `the culture run down' was not studied in detail, it did seem that if the inoculum was not transferred very frequently the surviving cells lost their ability to produce the antibiotics. For practical purposes best results were obtained when the culture was transferred every 24 hours. Inoculum levels for the fermentations were usually 5 % of a 24-hour culture (these usually contained 1 x 109 cfu per ml).
Determination of antibiotic activity. As initial experiments had shown that the antibiotic activity in the fermented medium dropped rather rapidly even upon storage in a refrigerator, an effort was made to stabilize the activity. The following procedure was used routinely: The samples of fermented medium were adjusted to pH 4.0 (using 2 N HCl) and subsequently heated to 80°C for 3 minutes. The samples were then centrifuged. Five ml of the supernatant solutions were adjusted to pH 6.5 (with 2 N NaOH) and lyophilized. The recovered solids were dissolved in 0.25 ml of water. These concentrates were assayed for antibiotic activity using an agar diffusion assay with 24-hour-old cells of Pseudomonas convexa NRRL B-21 in 10 ml of Difco assay medium 1 (in a 100-mm Petri dish) 8-mm wells in the agar served as reservoirs. The assay plates were incubated at 26°C for 18 hours. Kanamycin solutions served as a temporary internal standard.
In studying the antimicrobial spectrum of the purified antibiotics, the test organisms (see Table 5 ) were grown in nutrient broth (except for the Candida cultures which were grown in the SABOURAUD'S medium) for 24 hours and used to inoculate Difco assay agar no. 1. Paper discs (6.25 mm) were used as reservoirs, and zones of inhibition were measured after 18 hours at 37°C. 
Results and Discussion
Fermentation Studies Since during our previous work the production of the antibiotic by this culture was quite erratic, it was our first objective to improve this record. This was accomplished by use as inoculum for the fermentations of cells that had been growing in the log phase of growth (as mentioned above) and by using the shaken culture technique for the fermentation process. Some of the data showing that antibiotic activity was higher in shaken cultures than in static cultures are summarized in Table 1 and Fig. 1 . We also found higher maxima for cell counts (colony-forming units) in the shaken cultures (Table 1 and Fig. 1 ) where lower volumes of media were present in the Erlenmeyer flasks.
A study of the effect of composition of the fermentation medium on antibiotic productivity led to standardization at I % calf serum and addition of yeast extract to Difco PPLO broth (without crystal violet) used as the basal medium. Data collected in an experiment where the serum content of the medium was varied is summarized in Fig. 2 . The beneficial effects of acid mixture in the medium appeared to complicate the isolation of the antibiotics, this material was not routinely used as a component of the medium. The initial pH of the fermentation medium was found to be an important determinant of antibiotic yield. Some of the data obtained in a series of experiments are summarized in Fig. 4 .
For routine antibiotic production all media were adjusted with NaOH to pH 7.7 after autoclaving (and after addition of sterile calf serum to the medium).
Purification of Antibiotics
Preliminary studies showed that in the `active fermentations' there were acidic and basic antibiotics. The following procedure was used to isolate the basic antibiotic (Factor I): The fermented medium was adjusted to pH 4.5 with HCl and heated for 3 minutes in a 80°C water bath. After cooling to room temperature, the precipitate was removed by filtration through Whatman no. 1 paper. The filtrate was treated with Darco G-60 (30 g/liter filtrate) and the charcoal removed by filtration. The filtrate was evaporated to 1/20 volume by concentration in vacuo and extracted three times with equal volumes of ethyl acetate -methanol (9 : 1). The solvent layers were pooled and evaporated to dryness in vacuo. The residue was dissolved in a minimum of distilled water and passed over a Dowex 1 x 4 column (OH-form). The resulting effluent had a pH of 6.5. The antibiotic-containing solution was then applied to an Amberlite CG-50 (H+ cycle) column and the antibiotic was eluted by using a 0.2 N formic acid solution. The bioactive fractions were combined and concentrated in vacuo to dryness. The residue was dissolved in a minimum of methanol and sufficient ethyl ether was added to give a 1 : 1 mixture. The precipitate, formed on addition of ether, was removed by centrifugation. The supernatant was evaporated to dryness, the residue dissolved in water and rechromatographed on CG-50 resin (H+ cycle). The bioactive material was eluted with 0.2 N formic acid. The bioactive fractions were combined and passed through the Dowex 1 (OH-cycle) to remove excess acid. The bioactive fractions were then combined and evaporated to dryness in vacuo. The solids were dissolved in a minimum of methanol and ethyl ether was added until the solution became cloudy. The mixture was then placed at 4°C and after 15 days at this temperature The antibacterial potency of Factor I was lost when the solutions were stored at alkaline pH, or when the material was dissolved in acetone, or when it was lyophilized. Acidic solutions in water were stable for periods up to one month at 5°C. Spot tests showed positive reactions for the following reagents: CeSO4; I2; triphenyltetrazolium.
Negative tests were found with the following reagents: phosphotungstic acid; aniline phthalate; ninhydrin; resorcinol-HCl; orcinol; and anthrone.
Factor II proved to be stable in aqueous solutions at acid pH, but was found to be labile at alkaline pH (pH 8). Spot tests showed positive reactions for the following reagents: CeSO4; I2; phosphotungstic acid; triphenyltetrazolium. Negative reactions were obtained with the following reagents: aniline phthalate; ninhydrin; resorcinol-HCl; orcinol; anthrone.
The mobilities of Factors I and II in paper chromatographic and thin-layer chromatographic systems are summarized in Tables 3 and 4 .
Biological Characteristics of Factors I and II
The antimicrobial spectra of Factors I and II are summarized in Table 5 which also contains information on antibiotic activities of erythromycin, tetracycline, kanamycin, and gentamicin (complex). Most interesting is the potency of both Factors I and II against Pseudomonas strains. Cytotoxicity tests using the inhibition of growth of KB cells (according to the protocols of the National Cancer Institute) showed that purified Factor I had an ID50, of 8 mcg/ml and Factor II an ID50 of 5.7 ng/ml.
Thus, the cytotoxicity of Factor I is comparable with that of tetracycline or chloramphenicol, while the cytotoxicity of Factor II is of the order of the actinomycins in this test system.
In vivo tests using Pseudomonas aeruginosa and Staphylococcus aureus (Gray) as test organisms in mice showed that when crude Factor I (perhaps 10 % pure) was injected subcutaneously at 600 mg/kg, two of the three mice survived, while those mice not receiving the antibiotic died.
Further animal tests await production of more antibiotic material.
Studies of the mechanisms of action of these antibiotics have been limited so far by the lack of antibiotic material. In one study, using the agar diffusion assay with Bacillus subtilis n.z. * 6 .25 mm paper discs used; discs with Factor I contained 200 mcg; discs with Factor lI contained 20 mcg, disc; discs with erythromycin, kanamycin, tetracycline, and gentamicin all contained 5 mcg/disc. 
